Modafinil - Important Safety Information from Bluefish Pharmaceuticals as approved by HPRA

Notice type: 3rd Party Publications

Date: 28/08/2020

 

Problem Or Issue:
Important Safety Information from Bluefish Pharmaceuticals on Modafinil : Potential risk of congenital malformations when administered during pregnancy

Important Safety Information - Modafinil


« Back